These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25622102)

  • 21. Prescription Opioid Misuse and Risky Adolescent Behavior.
    Bhatia D; Mikulich-Gilbertson SK; Sakai JT
    Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31907292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US.
    Griesler PC; Hu MC; Wall MM; Kandel DB
    JAMA Netw Open; 2021 Jan; 4(1):e2031073. PubMed ID: 33410876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.
    Han BH; Sherman SE; Palamar JJ
    Prev Med; 2019 Apr; 121():94-98. PubMed ID: 30763631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol use and consequences in matriculating US college students by prescription stimulant/opioid nonmedical misuse status.
    Schepis TS; Acheson S; Zapp D; Swartzwelder HS
    Addict Behav; 2019 Nov; 98():106026. PubMed ID: 31415970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Misuse of Prescription Opioids and Suicidal Behaviors Among Black Adolescents: Findings from the 2017 and 2019 Youth Risk Behavior Survey.
    Baiden P; Eugene DR; Nicholas JK; Spoor S; Brown FA; LaBrenz CA
    J Racial Ethn Health Disparities; 2023 Aug; 10(4):1856-1868. PubMed ID: 35861928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife.
    McCabe SE; Veliz PT; Boyd CJ; Schepis TS; McCabe VV; Schulenberg JE
    Drug Alcohol Depend; 2019 Jan; 194():377-385. PubMed ID: 30481692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study.
    McCabe SE; Veliz P; Wilens TE; Schulenberg JE
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):226-233.e4. PubMed ID: 28219488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription Drug Misuse: Sources of Controlled Medications in Adolescents.
    Schepis TS; Wilens TE; McCabe SE
    J Am Acad Child Adolesc Psychiatry; 2019 Jul; 58(7):670-680.e4. PubMed ID: 30768405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diseases of Despair and Social Capital: Findings from a Population-Based Survey on Opioid Misuse among Adolescents.
    Jesmin SS; Amin I
    Subst Use Misuse; 2020; 55(12):1993-2001. PubMed ID: 32597297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National Trends in and Correlates of Nonmedical Use of Prescription Stimulants, Nonmedical Use Frequency, and Use Disorders.
    Han B; Jones CM; Blanco C; Compton WM
    J Clin Psychiatry; 2017; 78(9):e1250-e1258. PubMed ID: 29045771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic/Racial differences in peer and parent influence on adolescent prescription drug misuse.
    Conn BM; Marks AK
    J Dev Behav Pediatr; 2014 May; 35(4):257-65. PubMed ID: 24799264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paternal and maternal prescription opioid use and misuse: General and specific risks for early adolescents' substance use.
    Kerr DCR; Tiberio SS; Capaldi DM; Owen LD
    Addict Behav; 2020 Apr; 103():106248. PubMed ID: 31862621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription Stimulants: From Cognitive Enhancement to Misuse.
    Wilens TE; Kaminski TA
    Pediatr Clin North Am; 2019 Dec; 66(6):1109-1120. PubMed ID: 31679601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; Werner KS; McCabe VV; Veliz PT
    Psychiatr Serv; 2024 Jul; 75(7):622-629. PubMed ID: 38321920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System.
    Zosel A; Bartelson BB; Bailey E; Lowenstein S; Dart R
    J Am Acad Child Adolesc Psychiatry; 2013 Feb; 52(2):196-204.e2. PubMed ID: 23357446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are prescription misuse and illicit drug use etiologically distinct? A genetically-informed analysis of opioids and stimulants.
    Dash GF; Martin NG; Agrawal A; Lynskey MT; Slutske WS
    Psychol Med; 2022 Oct; 52(14):3176-3183. PubMed ID: 33455586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid and sedative misuse among veterans wounded in combat.
    Kelley ML; Bravo AJ; Votaw VR; Stein E; Redman JC; Witkiewitz K
    Addict Behav; 2019 May; 92():168-172. PubMed ID: 30640149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of concurrent substance use among adolescent nonmedical ADHD stimulant users.
    Chen LY; Crum RM; Strain EC; Martins SS; Mojtabai R
    Addict Behav; 2015 Oct; 49():1-6. PubMed ID: 26026384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personality and prescription drug use/misuse among first year undergraduates.
    Chinneck A; Thompson K; Mahu IT; Davis-MacNevin P; Dobson K; Stewart SH
    Addict Behav; 2018 Dec; 87():122-130. PubMed ID: 30005334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Opioid Misuse Among Individuals Aged 12 to 21 Years in the US.
    Warren LK; Adams J; Bobashev G
    JAMA Netw Open; 2023 Jun; 6(6):e2316276. PubMed ID: 37261827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.